市場調査レポート
商品コード
1287529
シングルセルマルチオミクス市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測Single Cell Multiomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
シングルセルマルチオミクス市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測 |
出版日: 2023年03月18日
発行: IMARC
ページ情報: 英文 147 Pages
納期: 2~3営業日
|
世界のシングルセルマルチオミクス市場規模は、2022年に34億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に17.6%の成長率(CAGR)を示し、2028年までに91億米ドルに達すると予測しています。
シングルセルマルチオミクスとは、細胞の多様性と異質性に関する洞察を得るために、個々の細胞から複数のタイプの分子を分析することを指します。単一細胞のゲノミクス、プロテオミクス、トランスクリプトミクス、メタボロミクスを含み、神経学、免疫学、細胞生物学、腫瘍学で広く使用されています。シングルセルマルチオミクスは、異種組織の集団アーキテクチャと細胞特性の理解を深めるのに役立ちます。単一細胞の分離・分注技術を利用し、分子層や複雑な生体構造の画像を提供します。従来から用いられているライブセル蛍光イメージング技術と比較して、シングルセルマルチオミクスは解析のために細胞を破壊する必要がなく、1つの細胞から複数種類の分子を測定することができます。そのため、バイオテクノロジーや製薬会社、病院、学術・研究機関、診断機関などで広く利用されています。
がんや感染性ウイルス疾患などの慢性疾患の有病率の上昇は、市場の成長を促進する重要な要因の1つです。シングルセルマルチオミクスは、腫瘍内の細胞成分の高解像度な景観を提供します。さらに、細胞の不均一性、腫瘍微小環境、抗体開発の可視化および解析のために広く製品が採用されていることが、市場の成長に好影響を与えています。さらに、デオキシリボ核酸(DNA)、メッセンジャーリボ核酸(mRNA)、タンパク質プロファイルを単一細胞の分解能で測定できる単一細胞分離およびバーコード技術の開拓など、さまざまな技術的進歩が市場成長の推進力となっています。これに伴い、製薬業界の著しい成長が、市場成長にプラスの影響を与えています。また、遺伝性疾患の治療に個別化医療を採用する動きが活発化していることや、ヘルスケアのインフラ整備が進んでいることも、市場の成長を後押しすると予想される要因です。
The global single cell multiomics market size reached US$ 3.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.1 Billion by 2028, exhibiting a growth rate (CAGR) of 17.6% during 2023-2028.
Single cell multiomics refers to the analysis of multiple types of molecules from an individual cell to gain insights regarding cellular diversity and heterogenity. It involves single cell genomics, proteomics, transcriptomics and metabolomics and is widely used in neurology, immunology, cell biology and oncology. Single cell multiomics aids in enhancing the understanding of population architectures and cellular properties of heterogeneous tissues. It utilizes single cell isolation and dispensing techniques to provide images of the molecular layers and complex biological structures. In comparison to the traditionally used live-cell fluorescence imaging techniques, single-cell multi-omics does not involve the destruction of cells for analysis and can measure multiple types of the molecule from a single cell. As a result, it is widely used across biotechnology and pharmaceutical organizations, hospitals, academics and research institutes and diagnostic laboratories.
The rising prevalence of chronic diseases, such as cancer and communicable viral diseases, is one of the key factors driving the growth of the market. Single cell multiomics provides a high-resolution landscape of cellular components in the tumors. Additionally, the widespread product adoption for visualization and analysis of cell heterogeneity, tumor micro-environment and antibody development are favoring the market growth. Moreover, various technological advancements, such as the development of single-cell isolation and barcoding technologies that enable deoxyribonucleic acid (DNA), messenger ribonucleic acid (mRNA) and protein profiles to be measured at a single-cell resolution, are providing a thrust to the market growth. In line with this, significant growth in the pharmaceutical industry is positively impacting the market growth. Other factors, including the increasing adoption of personalized medicine for the treatment of genetic disorders, along with the extensive improvements in the healthcare infrastructure, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global single cell multiomics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, product type, technique, application and end user.
Single Cell Genomics
Single Cell Proteomics
Single Cell Transcriptomics
Single Cell Metabolomics
Consumables
Instruments
Software
Single-Cell Isolation and Dispensing
Single-Cell Analysis
Oncology
Cell Biology
Neurology
Others
Academic Institutes
Contract Research Organizations
Pharmaceutical and Biotech Companies
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being 10x Genomics Inc., Becton Dickinson and Company, BGI Genomics (BGI Group), Bio-RAD Laboratories Inc., Fluidigm Corporation, Illumina Inc., Mission Bio, NanoCellect Biomedical, Nanostring Technologies Inc., Proteona, Takara Bio Inc. (Takara Holdings) and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report
1. What was the size of the global single cell multiomics market in 2022?
2. What is the expected growth rate of the global single cell multiomics market during 2023-2028?
3. What has been the impact of COVID-19 on the global single cell multiomics market?
4. What are the key factors driving the global single cell multiomics market?
5. What is the breakup of the global single cell multiomics market based on the type?
6. What is the breakup of the global single cell multiomics market based on the product type?
7. What is the breakup of the global single cell multiomics market based on the technique?
8. What is the breakup of the global single cell multiomics market based on the application?
9. What is the breakup of the global single cell multiomics market based on the end user?
10. What are the key regions in the global single cell multiomics market?
11. Who are the key players/companies in the global single cell multiomics market?